Pune/IBNS: Serum Institute of India (SII) said Tuesday the production of Covishield has been ramped up to 110 million doses this month, according to media reports.
New Delhi/IBNS: In a slight increase in daily cases, India on Thursday reported 48,786 new COVID-19 infections besides registering 1,005 deaths apparently due to the virus in the last 24 hours.
New Delhi/IBNS: India, which is slowly recovering from the second wave of coronavirus, on Thursday witnessed a big jump in daily COVID-19 toll as it recorded the highest number of deaths due to the contagion in the last 24 hours.
Delhi/IBNS: Amid shortage of vaccines that reportedly forced the Delhi government to stop inoculation drive for 18-44 age group, major supplies of both Covishield and Covaxin reached the national capital Wednesday.
Tokyo: Japan might extend help to Taiwan by supplying 1.24 million doses of the COVID-19 vaccine developed by Britain’s AstraZeneca PLC.
Bengaluru/UNI: Karnataka Minister for Health and Medical Education Dr K Sudhakar has said that the State has received 3 lakh Covishield doses from the Centre on Tuesday.
New Delhi/IBNS: The government on Thursday said Bharat Biotech's Covaxin and Serum Institute of India produced Covishield cannot be compared with each other, scientifically, to choose one over another.
New Delhi/IBNS: The Union health ministry on Sunday said that the online appointments, already made for the second dose of the Covishield vaccine, will not be cancelled on Co-WIN platform.
Srinagar: A fresh consignment of 50,000 Covishield vaccine doses from Serum Institute of India, Pune arrived in Srinagar on Wednesday.
New Delhi: The United States has identified sources of specific raw material urgently required for Indian manufacture of the Covishield vaccine that will immediately be made available for India, officials said on Sunday.
Pune/IBNS: The Serum Institute of India (SII) has decided to sell one dose of its Covid-19 vaccine, named Covishield, to state governments at Rs. 400 and private hospitals at Rs. 600, as India will enter into a liberalised vaccination drive from May 1.
New Delhi/UNI: A Subject Expert Committee (SEC) of central government on Monday gave its nod for the emergency use authorization of the Russia's COVID-19 vaccine SPUTNIK V, sources said.
The Bangladesh government has so far administered 4.8 million doses of Covishield to its people, and around 80,000 doses alone lasst Sunday. The registration portal for vaccines has already received 6.2 million applications. Bangladesh has procured over 9 million doses of vaccines so far, of which two million of them were donated by India.
New Delhi: The Centre on Monday directed the state to increase the interval between administering two doses of Covishield by 6-8 weeks for better results, officials said.
Pune/IBNS: Serum Institute of India (SII) CEO Adar Poonawalla on Sunday requested countries and governments to "be patient" amid the wait for 'Covishield' supplies, the coronavirus vaccine his pharmaceutical company has developed in partnership with the Oxford University and British-Swedish pharma firm AstraZeneca.